110 related articles for article (PubMed ID: 1363986)
1. [Sulfasalazine in the treatment of rheumatoid arthritis. A multicenter open study of 150 patients during 6 months].
Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):707-13. PubMed ID: 1363986
[TBL] [Abstract][Full Text] [Related]
2. Sulfasalazine therapy for juvenile rheumatoid arthritis.
Imundo LF; Jacobs JC
J Rheumatol; 1996 Feb; 23(2):360-6. PubMed ID: 8882047
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic maintenance and tolerance of sulfasalazine in rheumatoid polyarthritis. Retrospective study of 95 patients].
Pertuiset E; Lioté F; Chevret S; Bardin T; Dryll A; Kuntz D
Rev Rhum Mal Osteoartic; 1992 Oct; 59(9):545-52. PubMed ID: 1363000
[TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
Martin L; Sitar DS; Chalmers IM; Hunter T
J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
[TBL] [Abstract][Full Text] [Related]
5. [Sulfasalazine in rheumatoid arthritis].
Segal R; Caspi D; Sukenik S; Horowitz I; Rubinov A; Fluser D; Scharf Y; Shapira D; Weinberger A; Gedz D
Harefuah; 1991 May; 120(10):577-81. PubMed ID: 1682225
[TBL] [Abstract][Full Text] [Related]
6. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R;
J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
[TBL] [Abstract][Full Text] [Related]
7. Response to sulfasalazine in rheumatoid arthritis: life table analysis of a 5-year followup.
Jones E; Jones JV; Woodbury JF
J Rheumatol; 1991 Feb; 18(2):195-8. PubMed ID: 1673722
[TBL] [Abstract][Full Text] [Related]
8. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
[TBL] [Abstract][Full Text] [Related]
9. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
Yocum DE; Furst DE; Bensen WG; Burch FX; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisememandle W; Mekki QA;
Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
[TBL] [Abstract][Full Text] [Related]
10. A one-year, open, prospective study of sulfasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status.
Chalmers IM; Sitar DS; Hunter T
J Rheumatol; 1990 Jun; 17(6):764-70. PubMed ID: 1974926
[TBL] [Abstract][Full Text] [Related]
11. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
van Riel PL; van Gestel AM; van de Putte LB
Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
[TBL] [Abstract][Full Text] [Related]
12. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
13. The use of the AIMS questionnaire in the evaluation of sulphasalazine treatment in rheumatoid arthritis.
Pelísková Z; Trnavský K; Vácha J
Z Rheumatol; 1987; 46(3):124-8. PubMed ID: 2442919
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
Kremer JM; Habros JS; Kolba KS; Kaine JL; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisemandle W; Mekki QA;
Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
[TBL] [Abstract][Full Text] [Related]
15. Sulphasalazine in the treatment of rheumatoid arthritis.
Pelísková Z; Vácha J; Trnavský K
Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
[TBL] [Abstract][Full Text] [Related]
16. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
[TBL] [Abstract][Full Text] [Related]
17. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
Mundo A; Pedone V; Lamanna G; Cervini C
Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
[TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine has a better efficacy/toxicity profile than auranofin--evidence from a 5 year prospective, randomized trial.
McEntegart A; Porter D; Capell HA; Thomson EA
J Rheumatol; 1996 Nov; 23(11):1887-90. PubMed ID: 8923361
[TBL] [Abstract][Full Text] [Related]
19. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
20. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
O'Dell JR; Petersen K; Leff R; Palmer W; Schned E; Blakely K; Haire C; Fernandez A
J Rheumatol; 2006 Feb; 33(2):213-8. PubMed ID: 16358366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]